En Bloc Resection of Solitary Brain Metastasis: The Role of Perilesional Edema

Background/Aim: The treatment of solitary brain metastasis is a challenging intervention since the incidence increases and prognosis is poor. This study investigated the role of perilesional edema in the overall mass effect of solitary brain metastasis. Patients and Methods: We conducted a retrospective analysis on 88 patients with single supratentorial brain metastasis and concomitant perilesional edema undergoing en bloc resection. Each patient was evaluated for perilesional brain edema grading. We stratified patients into three groups based on the size of the metastatic lesion and the extent of perilesional edema. Results: The grade of perilesional edema at 30 days after surgical removal did not correlate with the maximum diameter of the metastasis (Pearson’s correlation 0.098, p=0.494). In patients with a maximal metastatic diameter ≤2 cm, the grade of perilesional edema before surgical treatment was 1.63 (STD 0.43), while 30 days after removal it was significantly reduced; 0.47 (STD 0.26), p<0.001. Conclusion: The overall mass effect of solitary supratentorial brain metastases is not correlated to the size of the lesion and the grade of the associated perilesional edema should be considered. Surgical en bloc resection can be considered the first choice of treatment in the presence of solitary metastasis ≤2 cm in maximal diameter but with high-grade edema, since this treatment reduces the overall mass effect.

[1]  A. Frati,et al.  RET/PTC3 translocation in a rare hemorrhagic brain metastasis of papillary thyroid cancer post Chernobyl radiation affects vessels ultrastructure , 2021, Interdisciplinary Neurosurgery.

[2]  Dihua Yu,et al.  Brain Metastasis Organotropism. , 2020, Cold Spring Harbor perspectives in medicine.

[3]  P. Iwanowski,et al.  Metastases to the central nervous system: Molecular basis and clinical considerations , 2020, Journal of the Neurological Sciences.

[4]  M. Ahluwalia,et al.  Current approaches to the management of brain metastases , 2020, Nature Reviews Clinical Oncology.

[5]  C. Barbaranelli,et al.  Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR , 2020, Brain sciences.

[6]  C. R. Goodwin,et al.  Operative and peri‐operative considerations in the management of brain metastasis , 2019, Cancer medicine.

[7]  P. Lockman,et al.  Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption. , 2019, Trends in cancer.

[8]  J. Olson,et al.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors , 2019, Neurosurgery.

[9]  D. Nguyen,et al.  Perilesional edema and blood vessel characteristics in brain metastases and implications for treatment with immune therapy. , 2018 .

[10]  S. F. Carbone,et al.  Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) , 2017, Neurological Sciences.

[11]  M. Mehta,et al.  What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases? , 2016, Journal of Neuro-Oncology.

[12]  H. Heinzl,et al.  Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases , 2016, Oncoimmunology.

[13]  V. Rohde,et al.  The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study , 2015, Oncotarget.

[14]  Akash J. Patel,et al.  Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis. , 2015, Journal of neurosurgery.

[15]  F. Dehghani,et al.  Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells , 2013, Journal of visualized experiments : JoVE.

[16]  J. Pichler,et al.  Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases , 2012, Clinical and Experimental Metastasis.

[17]  R. Jain,et al.  The biology of brain metastases—translation to new therapies , 2011, Nature Reviews Clinical Oncology.

[18]  Raymond Sawaya,et al.  Factors influencing the risk of local recurrence after resection of a single brain metastasis. , 2010, Journal of neurosurgery.

[19]  D. Kondziolka,et al.  The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[20]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[21]  G H Barnett,et al.  Pathobiology of brain metastases , 2005, Journal of Clinical Pathology.

[22]  Kintomo Takakura,et al.  Proton MRS of the peritumoral brain , 2005, Journal of the Neurological Sciences.

[23]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Hayashi,et al.  The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. , 2002, Anticancer research.

[25]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[26]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[27]  Jill S Barnholtz-Sloan,et al.  Brain metastases: epidemiology. , 2018, Handbook of clinical neurology.

[28]  M. Chamberlain,et al.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma. , 2017, Neuro-oncology.

[29]  N. Viñolas,et al.  Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. , 2005, International journal of radiation oncology, biology, physics.

[30]  R. Delfini,et al.  Solitary brain metastases from non-oat cell lung cancer: clinical and prognostic features , 2004, Neurosurgical Review.

[31]  E. Noordijk,et al.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. , 1994, International journal of radiation oncology, biology, physics.

[32]  R A Patchell,et al.  Brain metastases. , 1991, Neurologic clinics.